Scott Hadland MD

Scott Hadland, MD, MPH

Associate in Medicine

Instructor in Pediatrics, Harvard Medical School

  • Contact: 617-355-7181

  • Fax: 617-730-0184

Medical Services

Specialties

  • Adolescent Medicine
  • Pediatrics
  • Addiction Medicine

Departments

  • Adolescent Medicine
  • Medicine

Languages

  • English
  • French
  • Spanish

Programs

  • Adolescent Substance Abuse Program
  • Martha Eliot Health Center
  • Adolescent/Young Adult Medical Practice
To schedule an appointment: Call 617-355-7181 or Request an Appointment
Scott Hadland MD

 

I believe that we all need to give patients the time they deserve – to be present and involved in every patient interaction.  I never want my patients to feel rushed, or feel as though some part of their care was glossed over.

I entered medicine in order to provide outstanding care to patients struggling with problems that sometimes go unaddressed by the medical system.  For me, this means making sure I confront issues that might be considered too complicated by some, like questions of mental health or addiction.

Experience and Education

Education

Medical School

Washington University in St. Louis, 2009

St. Louis, MO

Internship

Boston Children's Hospital/Boston Medical Center, 2010

Boston, MA

Residency

Boston Children's Hospital/Boston Medical Center, 2012

Boston, MA

Chief Residency

Boston Children's Hospital/Boston Medical Center, 2013

Boston, MA

Fellowship, Adolescent Medicine

Boston Children's Hospital, 2015

Boston, MA

Certifications

  • Pediatrics

Professional History

My goal is to provide exceptional care to adolescents and young adults. Although I am a primary care physician by training, I am also a specialist in drug and alcohol addiction, and routinely provide care to youth who are lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ). Since 2007, I have conducted research in the field of substance use to understand the underpinnings of addiction and determine the most effective ways to treat it. Through my clinical work, research, and education, I hope to improve the well-being of vulnerable youth and invest in the health of generations to come.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduct J. 2016; 13(1):24.
  2. Hadland SE, Walker LR. Medical Comorbidity and Complications. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3):533-48.
  3. Hadland SE, Levy S. Objective Testing: Urine and Other Drug Tests. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3):549-65.
  4. Marshall BD, Green TC, Yedinak JL, Hadland SE. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. Int J Drug Policy. 2016 May; 31:25-31.
  5. Hadland SE, Knight JR, Harris SK. The Knowledge Gaps for Medical Marijuana in Pediatric Conditions. J Dev Behav Pediatr. 2015 Nov-Dec; 36(9):767-8.
  6. Hadland SE, Xuan Z, Blanchette JG, Heeren TC, Swahn MH, Naimi TS. Alcohol Policies and Alcoholic Cirrhosis Mortality in the United States. Prev Chronic Dis. 2015; 12:E177.
  7. Hadland SE, Knight JR. Brief Interventions for Alcohol Use: Where, When, and How? Pediatrics. 2015 Oct; 136(4):e1002-4.
  8. Hadland SE, Wood E, Dong H, Marshall BD, Kerr T, Montaner JS, DeBeck K. Suicide Attempts and Childhood Maltreatment Among Street Youth: A Prospective Cohort Study. Pediatrics. 2015 Sep; 136(3):440-9.
  9. Xuan Z, Blanchette JG, Nelson TF, Nguyen TH, Hadland SE, Oussayef NL, Heeren TC, Naimi TS. Youth Drinking in the United States: Relationships With Alcohol Policies and Adult Drinking. Pediatrics. 2015 Jul; 136(1):18-27.
  10. Hadland SE, Knight JR, Harris SK. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice. J Dev Behav Pediatr. 2015 Feb-Mar; 36(2):115-23.
  11. Show all
  12. Ostrom K, Syan R, Barber L, Miller D, Venkatasubramani N, Ravindra A, Jhaveri P, Jhaveri P, Alexander C, Nagan MR, Hauptman M, Grover A, Hadland SE. Index of suspicion. Pediatr Rev. 2014 Sep; 35(9):396-404.
  13. Hadland SE, Harris SK. Youth marijuana use: state of the science for the practicing clinician. Curr Opin Pediatr. 2014 Aug; 26(4):420-7.
  14. Hadland SE, DeBeck K, Kerr T, Feng C, Montaner JS, Wood E. Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth. BMJ Open. 2014; 4(7):e005419.
  15. Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E. Use of a medically supervised injection facility among street youth. J Adolesc Health. 2014 Nov; 55(5):684-9.
  16. Hadland SE, Long WE. A systematic review of the medical home for children without special health care needs. Matern Child Health J. 2014 May; 18(4):891-8.
  17. Hadland SE, Baer TE. The racial and ethnic gap in substance use treatment: implications for U.S. healthcare reform. J Adolesc Health. 2014 Jun; 54(6):627-8.
  18. Hadland SE, Austin SB, Goodenow CS, Calzo JP. Weight misperception and unhealthy weight control behaviors among sexual minorities in the general adolescent population. J Adolesc Health. 2014 Mar; 54(3):296-303.
  19. Marshall BD, Hadland SE. The immediate and lasting effects of adolescent homelessness on suicidal ideation and behavior. J Adolesc Health. 2012 Nov; 51(5):407-8.
  20. Hadland SE, Werb D, Kerr T, Fu E, Wang H, Montaner JS, Wood E. Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study. Prev Med. 2012 Nov; 55(5):500-4.
  21. Hadland SE, Marshall BD, Kerr T, Lai C, Montaner JS, Wood E. Ready access to illicit drugs among youth and adult users. Am J Addict. 2012 Sep-Oct; 21(5):488-90.
  22. Hadland SE, Wood E. Commentary on Bruneau et al. (2012): injection of prescription opioid pain relievers and infectious disease risk. Addiction. 2012 Jul; 107(7):1328-9.
  23. Hadland SE, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg RS, Montaner JS, Wood E. Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDS. 2012 May; 26(5):274-80.
  24. Hadland SE, Marshall BD, Kerr T, Qi J, Montaner JS, Wood E. Suicide and history of childhood trauma among street youth. J Affect Disord. 2012 Feb; 136(3):377-80.
  25. Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011; 46(12):1486-94.
  26. Hadland SE, Marshall BD, Kerr T, Qi J, Montaner JS, Wood E. Depressive symptoms and patterns of drug use among street youth. J Adolesc Health. 2011 Jun; 48(6):585-90.
  27. Hadland SE, Kerr T, Marshall BD, Small W, Lai C, Montaner JS, Wood E. Non-injection drug use patterns and history of injection among street youth. Eur Addict Res. 2010; 16(2):91-8.
  28. Hadland SE, Kerr T, Li K, Montaner JS, Wood E. Access to drug and alcohol treatment among a cohort of street-involved youth. Drug Alcohol Depend. 2009 Apr 1; 101(1-2):1-7.
To schedule an appointment: Call 617-355-7181 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close